What is Novavax's current ratio?

Novavax (NVAX) reported current ratio of 2.5× in Q1 2026.

How has Novavax's current ratio changed year-over-year?

Novavax's current ratio increased by 20.8% year-over-year, from 2.1× to 2.5×.

What is the long-term trend for Novavax's current ratio?

Over 5 years (2020 to 2025), Novavax's current ratio has grown at a -0.2% compound annual growth rate (CAGR), from 2.2× to 2.1×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

Novavax NVAX Current ratio

Current ratio at other companies

ModernaMRNA

2.4×-1.8×

Roivant SciencesROIV

18.4×-15.1×

Merck & Co.MRK

1.3×-0.1×

Vaxcyte, Inc.PCVX

7.5×-10.2×

Viridian Therapeutics, Inc.VRDN

15.1×-4.3×

ALN

Alnylam PharmaceuticalsALNY

3.1×+0.1×

Other financials

Income statement

See full

Revenue$139.5M-79.1%

Gross profit$108.8M-83.3%

Operating income-$15.4M-103%

Net income-$9.5M-102%

EPS (diluted)-$0.06-102%

Balance sheet

See full

Cash & equivalents$228.4M-13.3%

Total debt$295.1M+404%

Total equity-$144.8M-91.4%

Total assets$1.0B-19.3%

Cash flow

See full

Operating cash flow-$32.4M+82.5%

CapEx$1.3M-20.4%

Free cash flow-$33.7M+82.0%

Valuation

See full

Market cap$1.46B+28.6%

Enterprise value$1.53B+68.6%

P/S2.5×+1.5×

Profitability

See full

Gross margin85%-2.5pp

Operating margin-13.1%-45.9pp

Net margin-14.7%-52.9pp

FCF margin-58.9%-61.4pp

Returns & leverage

See full

Return on equity-238.6%—

Debt / equity1.5×—

Where this comes from

Calculated from Novavax’s reported figures.

total current assets/total current liabilities=2.5×

Based on the most recent quarter.

The official record: Novavax’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Novavax's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Novavax's current ratio?: Novavax (NVAX) reported current ratio of 2.5× in Q1 2026.
How has Novavax's current ratio changed year-over-year?: Novavax's current ratio increased by 20.8% year-over-year, from 2.1× to 2.5×.
What is the long-term trend for Novavax's current ratio?: Over 5 years (2020 to 2025), Novavax's current ratio has grown at a -0.2% compound annual growth rate (CAGR), from 2.2× to 2.1×.
What does current ratio mean?: Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.